Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-15-392044
Filing Date
2015-12-01
Accepted
2015-12-01 16:24:58
Documents
11

Document Format Files

Seq Description Document Type Size
1 424(B)(3) d13809d424b3.htm 424B3 1774515
2 GRAPHIC g13809g20u79.jpg GRAPHIC 3747
3 GRAPHIC g13809g31u25.jpg GRAPHIC 15704
4 GRAPHIC g13809g59z83.jpg GRAPHIC 10685
5 GRAPHIC g13809g67g57.jpg GRAPHIC 24822
6 GRAPHIC g13809g77c39.jpg GRAPHIC 6531
7 GRAPHIC g13809g80p87.jpg GRAPHIC 3438
8 GRAPHIC g13809g82l96.jpg GRAPHIC 6142
9 GRAPHIC g13809g83p86.jpg GRAPHIC 34632
10 GRAPHIC g13809g83w37.jpg GRAPHIC 22760
11 GRAPHIC g13809g93f71.jpg GRAPHIC 9354
  Complete submission text file 0001193125-15-392044.txt   1961251
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-207421 | Film No.: 151262677
SIC: 2834 Pharmaceutical Preparations